Cargando…

Determinants and clinical outcomes of patients who refused anticoagulation: findings from the global GARFIELD-AF registry

OBJECTIVE: There is a substantial incidence of stroke in patients with atrial fibrillation (AF) not receiving anticoagulation. The reasons for not receiving anticoagulation are generally attributed to clinician’s choice, however, a proportion of AF patients refuse anticoagulation. The aim of our stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Apenteng, Patricia, Virdone, Saverio, Camm, John, Fox, Keith A A, Bassand, Jean-Pierre, Turpie, Alexander G G, Oh, Seil, Brodmann, Marianne, Cools, Frank, Barretto, Antonio C P, Nielsen, Jørn, Haas, Sylvia, Kayani, Gloria, Pieper, Karen S, Kakkar, Ajay K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Special Populations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410826/ https://www.ncbi.nlm.nih.gov/pubmed/37169491 http://dx.doi.org/10.1136/openhrt-2023-002275

Ejemplares similares

Characteristics, treatment, and outcomes of newly diagnosed atrial fibrillation patients with heart failure: GARFIELD‐AF
por: Ambrosio, Giuseppe, et al.
Publicado: (2021)

Guideline-directed medical therapies for comorbidities among patients with atrial fibrillation: results from GARFIELD-AF
por: Camm, Alan John, et al.
Publicado: (2023)

Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD‐AF Registry
por: Cools, Frank, et al.
Publicado: (2021)

Predictors of intracranial hemorrhage in patients with atrial fibrillation treated with oral anticoagulants: Insights from the GARFIELD‐AF and ORBIT‐AF registries
por: Lim, Toon Wei, et al.
Publicado: (2023)

GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation
por: Fox, Keith A A, et al.
Publicado: (2021)

Two-year outcomes of UK patients newly diagnosed with atrial fibrillation: findings from the prospective observational cohort study GARFIELD-AF
por: Apenteng, Patricia N, et al.
Publicado: (2022)

Association of body mass index with outcomes in patients with newly diagnosed atrial fibrillation: GARFIELD-AF
por: Camm, Christian Fielder, et al.
Publicado: (2022)

Healthcare Resource Utilization in Patients with Newly Diagnosed Atrial Fibrillation: A Global Analysis from the GARFIELD-AF Registry
por: Mantovani, Lorenzo G., et al.
Publicado: (2023)

Do baseline characteristics and treatments account for geographical disparities in the outcomes of patients with newly diagnosed atrial fibrillation? The prospective GARFIELD-AF registry
por: Fox, Keith A A, et al.
Publicado: (2022)

Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation
por: Fox, Keith A A, et al.
Publicado: (2017)

Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF
por: Bassand, Jean-Pierre, et al.
Publicado: (2016)

Rhythm versus rate control in patients with newly diagnosed atrial fibrillation – Observations from the GARFIELD-AF registry
por: Knudsen Pope, Marita, et al.
Publicado: (2023)

Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation – results from the GARFIELD-AF registry
por: Pope, Marita Knudsen, et al.
Publicado: (2021)

Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry
por: Goto, Shinya, et al.
Publicado: (2019)

Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry
por: Haas, Sylvia, et al.
Publicado: (2016)

Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation
por: Bassand, Jean-Pierre, et al.
Publicado: (2018)

New artificial intelligence prediction model using serial prothrombin time international normalized ratio measurements in atrial fibrillation patients on vitamin K antagonists: GARFIELD-AF
por: Goto, Shinichi, et al.
Publicado: (2019)

Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry
por: Camm, A John, et al.
Publicado: (2017)

The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events
por: Atar, Dan, et al.
Publicado: (2020)

Stroke prevention in patients from Latin American countries with non‐valvular atrial fibrillation: Insights from the GARFIELD‐AF registry
por: Jerjes‐Sanchez, Carlos, et al.
Publicado: (2019)

Comparative effectiveness of oral anticoagulants in everyday practice
por: Camm, A John, et al.
Publicado: (2021)

Impact of different anticoagulation management strategies on outcomes in atrial fibrillation: Dutch and Belgian results from the GARFIELD‐AF registry
por: Seelig, Jaap, et al.
Publicado: (2020)

On-treatment Comparative Effectiveness of Vitamin K Antagonists and Direct Oral Anticoagulants in GARFIELD-VTE, and Focus on Cancer and Renal Disease
por: Haas, Sylvia, et al.
Publicado: (2022)

GARFIELD-AF model for prediction of stroke and major bleeding in atrial fibrillation: a Danish nationwide validation study
por: Dalgaard, Frederik, et al.
Publicado: (2019)

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry
por: Sawhney, Jitendra PS., et al.
Publicado: (2018)

Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD‐VTE
por: Ageno, Walter, et al.
Publicado: (2021)

Changes in anticoagulant prescription in Dutch patients with recent-onset atrial fibrillation: observations from the GARFIELD-AF registry
por: Seelig, J., et al.
Publicado: (2020)

Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE
por: Jerjes-Sánchez, Carlos, et al.
Publicado: (2021)

Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry
por: Kakkar, Ajay K., et al.
Publicado: (2013)

Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry
por: Apenteng, Patricia N, et al.
Publicado: (2018)

Management strategies and clinical outcomes in patients with inferior vena cava thrombosis: Data from GARFIELD‐VTE
por: Cohen, Omri, et al.
Publicado: (2021)

Optimising prediction of mortality, stroke, and major bleeding for patients with atrial fibrillation: validation of the GARFIELD-AF tool in UK primary care electronic records
por: Apenteng, Patricia N, et al.
Publicado: (2023)

The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF): Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands
por: ten Cate, V., et al.
Publicado: (2016)

International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)
por: Beyer-Westendorf, Jan, et al.
Publicado: (2019)

Erratum to: The Global Anticoagulant Registry in the FIELD – Atrial Fibrillation (GARFIELD-AF): Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands
por: ten Cate, V., et al.
Publicado: (2016)

Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS‐BLED and GARFIELD‐AF Bleeding Scores
por: Proietti, Marco, et al.
Publicado: (2018)

Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation
por: Fox, Keith A. A., et al.
Publicado: (2020)

Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
por: Camm, A John, et al.
Publicado: (2017)

Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial
por: Cools, Frank, et al.
Publicado: (2022)

An international longitudinal registry of patients with atrial fibrillation at risk of stroke (GARFIELD): the UK protocol
por: Apenteng, Patricia N, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_l78f4m8a9v7l7quc1sqp60qu0u